Clinical Trial Update: Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post-traumatic Acute Pain in the Emergency Department ( INVESCK ) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing intranasal ketamine to subcutaneous ketamine for acute pain in the emergency department, conducted in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of Monastir | Conditions: Acute Pain | Phase 2, Phase 3 | Status: UNKNOWN